InsiderClue
Stocks · Health care · Pharmaceutical Preparations

ARDELYX, INC.

ARDX Clue Score56
United States Fiscal year ends December CIK 0001437402 Results filed 3 Nov 2026
Add to watchlist

What the insiders did Balanced

Individual transactions

79
Insider
Date
Role
Action
Shares
Price
Amount
Michael Raab
21 Aug 2026
President & CEO
Sell
19,178
$3.86
$73.97K
Michael Raab
21 Aug 2026
President & CEO
Sell
8,411
$3.86
$32.44K
Michael Raab
21 Aug 2026
President & CEO
Sell
15,976
$3.86
$61.62K
Michael Raab
21 Aug 2026
President & CEO
Sell
15,009
$3.86
$57.89K
Laura A Williams
21 Aug 2026
Chief Patient Officer
Sell
1,734
$3.86
$6.69K
Laura A Williams
21 Aug 2026
Chief Patient Officer
Sell
2,430
$3.86
$9.37K
Laura A Williams
21 Aug 2026
Chief Patient Officer
Sell
3,089
$3.86
$11.91K
Laura A Williams
21 Aug 2026
Chief Patient Officer
Sell
3,486
$3.86
$13.45K
Mike Kelliher
21 Aug 2026
Chief Business Officer
Sell
2,002
$3.86
$7.72K
Mike Kelliher
21 Aug 2026
Chief Business Officer
Sell
2,652
$3.86
$10.23K
Mike Kelliher
21 Aug 2026
Chief Business Officer
Sell
3,104
$3.86
$11.97K
Eric Duane Foster
21 Aug 2026
Chief Commercial Officer
Sell
2,575
$3.86
$9.93K
Eric Duane Foster
21 Aug 2026
Chief Commercial Officer
Sell
3,389
$3.86
$13.07K
Eric Duane Foster
21 Aug 2026
Chief Commercial Officer
Sell
2,598
$3.86
$10.02K
James Parker Brady
21 Aug 2026
Chief Human Resources Officer
Sell
13,160
$3.86
$50.76K
James Parker Brady
21 Aug 2026
Chief Human Resources Officer
Sell
1,976
$3.86
$7.62K
John E Bishop
21 Aug 2026
See Remarks
Sell
2,469
$3.86
$9.52K
John E Bishop
21 Aug 2026
See Remarks
Sell
17,281
$3.86
$66.65K
Joseph James Reilly
21 Aug 2026
See Remarks
Sell
1,110
$3.86
$4.28K
Joseph James Reilly
21 Aug 2026
See Remarks
Sell
2,872
$3.86
$11.08K
Susan Hohenleitner
21 Aug 2026
Chief Financial Officer
Sell
1,558
$3.86
$6.01K
Michael Raab
15 Jul 2026
President & CEO
Sold after exercise
41,668
$5.06
$210.92K
Laura A Williams
18 Jun 2026
Chief Patient Officer
Sold after exercise
81,898
$5.99
$490.49K
Michael Raab
15 Jun 2026
President & CEO
Sold after exercise
41,666
$5.67
$236.35K
Michael Raab
21 May 2026
President & CEO
Sell
14,028
$6.27
$87.92K
Michael Raab
21 May 2026
President & CEO
Sell
17,926
$6.27
$112.35K
Michael Raab
21 May 2026
President & CEO
Sell
7,861
$6.27
$49.27K
Michael Raab
21 May 2026
President & CEO
Sell
14,933
$6.27
$93.59K
Laura A Williams
21 May 2026
Chief Patient Officer
Sell
1,418
$6.27
$8.89K
Laura A Williams
21 May 2026
Chief Patient Officer
Sell
1,911
$6.27
$11.98K
Laura A Williams
21 May 2026
Chief Patient Officer
Sell
2,157
$6.27
$13.52K
Laura A Williams
21 May 2026
Chief Patient Officer
Sell
1,503
$6.27
$9.42K
Mike Kelliher
21 May 2026
Chief Business Officer
Sell
2,478
$6.27
$15.53K
Mike Kelliher
21 May 2026
Chief Business Officer
Sell
1,870
$6.27
$11.72K
Mike Kelliher
21 May 2026
Chief Business Officer
Sell
2,900
$6.27
$18.18K
Eric Duane Foster
21 May 2026
Chief Commercial Officer
Sell
2,405
$6.27
$15.07K
Eric Duane Foster
21 May 2026
Chief Commercial Officer
Sell
2,427
$6.27
$15.21K
Eric Duane Foster
21 May 2026
Chief Commercial Officer
Sell
3,166
$6.27
$19.84K
James Parker Brady
21 May 2026
Chief Human Resources Officer
Sell
1,846
$6.27
$11.57K
John E Bishop
21 May 2026
See Remarks
Sell
2,306
$6.27
$14.45K
Susan Hohenleitner
21 May 2026
Chief Financial Officer
Sell
1,455
$6.27
$9.12K
Joseph James Reilly
21 May 2026
See Remarks
Sell
1,036
$6.27
$6.49K
Joseph James Reilly
21 May 2026
See Remarks
Sell
2,683
$6.27
$16.82K
Michael Raab
15 May 2026
President & CEO
Sold after exercise
41,666
$6.28
$261.61K
Michael Raab
15 Apr 2026
President & CEO
Sold after exercise
41,668
$6.29
$261.95K
Michael Raab
16 Mar 2026
President & CEO
Sold after exercise
41,666
$5.84
$243.33K
Michael Raab
24 Feb 2026
President & CEO
Sold after exercise
41,666
$6.26
$260.62K
Eric Duane Foster
20 Feb 2026
Chief Commercial Officer
Sell
1
$5.70
$5.70
Eric Duane Foster
20 Feb 2026
Chief Commercial Officer
Sell
1
$5.71
$5.71
Eric Duane Foster
20 Feb 2026
Chief Commercial Officer
Sell
1,261
$5.71
$7.21K
Eric Duane Foster
20 Feb 2026
Chief Commercial Officer
Sell
9,176
$5.87
$53.82K
Michael Raab
20 Feb 2026
President & CEO
Sell
2
$5.70
$11.40
Michael Raab
20 Feb 2026
President & CEO
Sell
1
$5.70
$5.70
Michael Raab
20 Feb 2026
President & CEO
Sell
2
$5.70
$11.40
Michael Raab
20 Feb 2026
President & CEO
Sell
5,576
$5.71
$31.86K
Michael Raab
20 Feb 2026
President & CEO
Sell
40,401
$5.87
$236.95K
Mike Kelliher
20 Feb 2026
See Remarks
Sell
2
$5.71
$11.41
Mike Kelliher
20 Feb 2026
See Remarks
Sell
1,159
$5.71
$6.62K
Mike Kelliher
20 Feb 2026
See Remarks
Sell
8,434
$5.87
$49.47K
James Parker Brady
20 Feb 2026
Chief Human Resources Officer
Sell
309
$5.71
$1.77K
James Parker Brady
20 Feb 2026
Chief Human Resources Officer
Sell
2,234
$5.87
$13.10K
Susan Hohenleitner
20 Feb 2026
Chief Financial Officer
Sell
247
$5.71
$1.41K
Susan Hohenleitner
20 Feb 2026
Chief Financial Officer
Sell
1,786
$5.87
$10.47K
Laura A Williams
20 Feb 2026
See Remarks
Sell
984
$5.71
$5.62K
Laura A Williams
20 Feb 2026
See Remarks
Sell
7,192
$5.87
$42.18K
Joseph James Reilly
20 Feb 2026
See Remarks
Sell
2
$5.70
$11.40
Joseph James Reilly
20 Feb 2026
See Remarks
Sell
602
$5.71
$3.44K
Joseph James Reilly
20 Feb 2026
See Remarks
Sell
4,387
$5.87
$25.73K
John E Bishop
20 Feb 2026
See Remarks
Sell
1
$5.70
$5.70
John E Bishop
20 Feb 2026
See Remarks
Sell
386
$5.71
$2.21K
John E Bishop
20 Feb 2026
See Remarks
Sell
2,792
$5.87
$16.38K
David M Mott
20 Feb 2026
Director
Buy
333,333
$5.84
$1.95M
Laura A Williams
8 Jan 2026
Chief Patient Officer
Sold after exercise
50,000
$6.98
$348.90K
Joseph James Reilly
21 Nov 2025
See Remarks
Sell
11,086
$5.54
$61.38K
Eric Duane Foster
21 Nov 2025
Chief Commercial Officer
Sell
5,814
$5.54
$32.19K
Laura A Williams
21 Nov 2025
Chief Patient Officer
Sell
6,426
$5.54
$35.58K
Mike Kelliher
21 Nov 2025
See Remarks
Sell
5,560
$5.54
$30.79K
Michael Raab
21 Nov 2025
President & CEO
Sell
46,887
$5.54
$259.61K
Elizabeth A Grammer
21 Nov 2025
See Remarks
Sell
5,995
$5.54
$33.19K

What was left out

Form 4 filings counted 54
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 8
Sales at will 70
Transactions with no price 0
Shares from compensation/vesting 1,549,407
History held since 18 Jun 2014